Skip Nav Destination
Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion
A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT
Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial
Issue Archive
August 1 2000
In this Issue
Table of Contents
PLENARY PAPERS
Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects
Ronald T. Mitsuyasu,Peter A. Anton,Steven G. Deeks,David T. Scadden,Elizabeth Connick,Matthew T. Downs,Andreas Bakker,Margo R. Roberts,Carl H. June,Sayeh Jalali,Andy A. Lin,Rukmini Pennathur-Das,Kristen M. Hege
ERRATA
REVIEW ARTICLES
CHEMOKINES
Induction of monocyte– and T-cell–attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation
Angela Panoskaltsis-Mortari,Robert M. Strieter,John R. Hermanson,Konstantin V. Fegeding,William J. Murphy,Catherine L. Farrell,David L. Lacey,Bruce R. Blazar
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients
Clinical Trials & Observations
Pierre Morel,Mathieu Monconduit,Dominique Jacomy,Pascal Lenain,Bernard Grosbois,Christine Bateli,Thierry Facon,Isabelle Dervite,Francis Bauters,Albert Najman,Aimery de Gramont,Eric Wattel
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion
Clinical Trials & Observations
Michele Magni,Massimo Di Nicola,Liliana Devizzi,Paola Matteucci,Fabrizio Lombardi,Lorenza Gandola,Fernando Ravagnani,Roberto Giardini,Giuseppe Dastoli,Corrado Tarella,Alessandro Pileri,Gianni Bonadonna,Alessandro M. Gianni
GENE THERAPY
HEMATOPOIESIS
A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction
Yoshifumi Kashii,Mie Uchida,Keita Kirito,Masaru Tanaka,Kousuke Nishijima,Masaki Toshima,Tomoko Ando,Kazuki Koizumi,Tomoyuki Endoh,Ken-ichi Sawada,Mariko Momoi,Yasusada Miura,Keiya Ozawa,Norio Komatsu
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
Marc Jacquemin,Renaud Lavend'homme,Abdellah Benhida,Beatrijs Vanzieleghem,Roseline d'Oiron,Jean-Maurice Lavergne,Hans H. Brackmann,Rainer Schwaab,Thierry VandenDriessche,Marinee K. L. Chuah,Marc Hoylaerts,Jean Guy G. Gilles,Kathelijne Peerlinck,Jos Vermylen,Jean-Marie R. Saint-Remy
IMMUNOBIOLOGY
NEOPLASIA
TEL/AML1 gene fusion is related to in vitro drug sensitivity forl-asparaginase in childhood acute lymphoblastic leukemia
Nicole L. Ramakers-van Woerden,Rob Pieters,Annemarie H. Loonen,Isabelle Hubeek,Ellen van Drunen,H. Berna Beverloo,Rosalyn M. Slater,Jochen Harbott,Jeanette Seyfarth,Elisabeth R. van Wering,Karel Hählen,Kjeld Schmiegelow,Gritta E. Janka-Schaub,Anjo J. P. Veerman
PHAGOCYTES
RED CELLS
Triose phosphate isomerase deficiency in 3 French families: two novel null alleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris)
Colette Valentin,Serge Pissard,Josiane Martin,Delphine Héron,Philippe Labrune,Marie-Odile Livet,Michèle Mayer,Terri Gelbart,Arthur Schneider,Isabelle Max-Audit,Michel Cohen-Solal
TRANSFUSION MEDICINE
TRANSPLANTATION
Molecular modification of a recombinant anti-CD3ε-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model
Daniel A. Vallera,David W. Kuroki,Angela Panoskaltsis-Mortari,Donald J. Buchsbaum,Buck E. Rogers,Bruce R. Blazar
A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT
Clinical Trials & Observations
BRIEF REPORTS
CORRESPONDENCE
Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial
Clinical Trials & Observations
H. Joachim Deeg,Mary E. D. Flowers,Wendy Leisenring,Frederick R. Appelbaum,Paul J. Martin,Rainer F. Storb
10
17
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals